Clostridium botulinum type B neurotoxin cleaves VAMP (vesicle-associated me
mbrane protein)/synaptobrevin into two fragments, which results in inhibiti
on of neurotransmitter release. The induced fragment did not react to the a
ntibody raised against the synthetic peptide of the amino-terminal 20 resid
ues of VAMP-2, suggesting that the toxin treatment has caused antigenical a
lteration in the amino-terminal region of VAMP-2. In rat brain synaptosomes
, type B neurotoxin was reduced presumably with sulfhydryls in the membrane
and detected in the synaptic vesicle fraction which involved the degradati
on of VAMP-2 and the inhibition of neurotransmitter release. The light chai
n in a free form was present in the cytosol fraction. These findings sugges
t a possibility that type B neurotoxin endocytoses into synaptic vesicles b
y the recycling pathway and the light chain is penetrable through synaptic
vesicle membrane. However, the amount of type B neurotoxin entrapped into s
ynaptic vesicles appears to be extremely small, which may be attributed to
a lower sensitivity of the toxin to brain synaptosomes than to peripheral n
erve endings.